Alyeska Investment Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,027
| Closed | -$206K | – | 590 |
|
|
2024
Q3 | $206K | Buy |
+3,027
| New | +$206K | ﹤0.01% | 505 |
|
|
2024
Q2 | – | Sell |
-150,000
| Closed | -$10.4M | – | 539 |
|
|
2024
Q1 | $10.4M | Sell |
150,000
-175,000
| -54% | -$12.1M | 0.06% | 269 |
|
|
2023
Q4 | $24M | Sell |
325,000
-736,052
| -69% | -$54.5M | 0.16% | 178 |
|
|
2023
Q3 | $72.4M | Buy |
1,061,052
+710,428
| +203% | +$48.5M | 0.49% | 61 |
|
|
2023
Q2 | $32.9M | Buy |
+350,624
| New | +$32.9M | 0.24% | 135 |
|
|
2022
Q1 | – | Sell |
-75,000
| Closed | -$5.84M | – | 601 |
|
|
2021
Q4 | $5.84M | Buy |
+75,000
| New | +$5.84M | 0.07% | 261 |
|
|
2020
Q4 | – | Sell |
-54,858
| Closed | -$5.59M | – | 532 |
|
|
2020
Q3 | $5.59M | Buy |
+54,858
| New | +$5.59M | 0.09% | 244 |
|
|
2019
Q1 | – | Sell |
-191,389
| Closed | -$12.1M | – | 357 |
|
|
2018
Q4 | $12.1M | Sell |
191,389
-28,738
| -13% | -$1.81M | 0.18% | 147 |
|
|
2018
Q3 | $17.4M | Buy |
+220,127
| New | +$17.4M | 0.19% | 134 |
|
|
2017
Q3 | – | Sell |
-450,447
| Closed | -$15.9M | – | 452 |
|
|
2017
Q2 | $15.9M | Sell |
450,447
-327,301
| -42% | -$11.6M | 0.13% | 196 |
|
|
2017
Q1 | $18.4M | Buy |
+777,748
| New | +$18.4M | 0.15% | 196 |
|
|
2016
Q1 | – | Sell |
-97,569
| Closed | -$901K | – | 393 |
|
|
2015
Q4 | $901K | Buy |
97,569
+32,861
| +51% | +$303K | 0.01% | 336 |
|
|
2015
Q3 | $1.16M | Buy |
64,708
+49,098
| +315% | +$883K | 0.01% | 373 |
|
|
2015
Q2 | $464K | Sell |
15,610
-13,560
| -46% | -$403K | 0.01% | 432 |
|
|
2015
Q1 | $642K | Buy |
+29,170
| New | +$642K | 0.01% | 433 |
|
|
2013
Q4 | – | Sell |
-213,912
| Closed | -$2.52M | – | 285 |
|
|
2013
Q3 | $2.52M | Sell |
213,912
-200,000
| -48% | -$2.36M | 0.1% | 165 |
|
|
2013
Q2 | $5.76M | Buy |
+413,912
| New | +$5.76M | 0.28% | 95 |
|